Diagnosis of post-transplant lymphoproliferative disorder in solid organ transplant recipients - BCSH and BTS Guidelines

British Journal of Haematology

Volumn 149, Issue 5, 2010, Pages 675-692

  Parker, Anne ^a,j   Bowles, Kristin ^b   Bradley, J Andrew ^c   Emery, Vincent ^d   Featherstone, Carrie ^a   Gupte, Girish ^e   Marcus, Robert ^f   Parameshwar, Jayan ^g   Ramsay, Alan ^h   Newstead, Charles ⁱ  

^a BEATSON WEST OF SCOTLAND CANCER CENTRE   (United Kingdom)

^b NORFOLK AND NORWICH HOSPITAL   (United Kingdom)

^c ADDENBROOKE S HOSPITAL   (United Kingdom)

^d UNIVERSITY COLLEGE LONDON   (United Kingdom)

^e BIRMINGHAM CHILDREN S HOSPITAL   (United Kingdom)

^f KING S COLLEGE HOSPITAL   (United Kingdom)

^g PAPWORTH HOSPITAL   (United Kingdom)

^h UNIVERSITY COLLEGE HOSPITAL   (United Kingdom)

ⁱ ST JAMES S UNIVERSITY HOSPITAL   (United Kingdom)

^j British Society for Haematology   (United Kingdom)

more..

Author keywords

Diagnostic haematology; EBV; Lymphoproliferative disease; Transplant

Indexed keywords

ALEMTUZUMAB; AZATHIOPRINE; BASILIXIMAB; CALCINEURIN INHIBITOR; CYCLOSPORIN A; INTERLEUKIN 2 RECEPTOR ANTIBODY; MYCOPHENOLIC ACID 2 MORPHOLINOETHYL ESTER; OKT 3; PREDNISONE; RAPAMYCIN; TACROLIMUS; THYMOCYTE ANTIBODY;

AGE DISTRIBUTION; CELLULAR IMMUNITY; CLINICAL FEATURE; DIFFERENTIAL DIAGNOSIS; DISEASE CLASSIFICATION; DISEASE COURSE; DRUG SUBSTITUTION; DRUG WITHDRAWAL; EPSTEIN BARR VIRUS INFECTION; ETHNICITY; GRAFT VERSUS HOST REACTION; HISTOPATHOLOGY; HUMAN; IMMUNOPHENOTYPING; IMMUNOSUPPRESSIVE TREATMENT; LYMPHOPROLIFERATIVE DISEASE; MEDICAL SOCIETY; ORGAN TRANSPLANTATION; PATIENT MONITORING; POST TRANSPLANT LYMPHOPROLIFERATIVE DISEASE; PRACTICE GUIDELINE; PRIORITY JOURNAL; REVIEW; RISK FACTOR; VIRUS REACTIVATION;

EPSTEIN-BARR VIRUS INFECTIONS; HUMANS; LYMPHOPROLIFERATIVE DISORDERS; ORGAN TRANSPLANTATION; POPULATION SURVEILLANCE; POSTOPERATIVE CARE; PREOPERATIVE CARE; RISK FACTORS;

EID: 77952718329     PISSN: 00071048     EISSN: 13652141     Source Type: Journal    
DOI: 10.1111/j.1365-2141.2010.08161.x     Document Type: Review

References (128)

1. Ali, M.G., Coakley, F.V., Hricak, H. Bretan, P.N. (1999) Complex posttransplantation abnormalities of renal allografts: evaluation with MR imaging. Radiology, 211, 95 100.
2. Allen, U., Hebert, D., Moore, D., Dror, Y., Wasfy, S. the Canadian PTLD Survey Group - 1998 (2001) Epstein-Barr virus-related post-transplant lymphoproliferative disease in solid organ transplant recipients, 1988-97: a Canadian multi-centre experience. Pediatric Transplantation, 5, 198 203.
3. Amlot, P.L., Tahami, F., Chinn, D. Rawlings, E. (1996) Activation antigen expression on human T cells. I. Analysis by two-colour flow cytometry of umbilical cord blood, adult blood and lymphoid tissue. Clinical & Experimental Immunology, 105, 176 182.
4. d'Amore, F., Johansen, P., Houmand, A., Weisenburger, D.D. Mortensen, L.S. (1996) Epstein-Barr virus genome in non-Hodgkin's lymphomas occurring in immunocompetent patients: highest prevalence in nonlymphoblastic T-cell lymphoma and correlation with a poor prognosis. Danish Lymphoma Study Group, LYFO. Blood, 87, 1045 1055.
5. Aull, M.J., Buell, J.F., Peddi, V.R., Trofe, J., Beebe, T.M., Hanaway, M.J., Roy-Chaudhury, P., Alloway, R.R., First, M.R., Woodle, E.S. Israel Penn International Transplant Tumor, R. (2003) MALToma: a Helicobacter pylori-associated malignancy in transplant patients: a report from the Israel Penn International Transplant Tumor Registry with a review of published literature. Transplantation, 75, 225 228.
6. Bakker, N.A., Pruim, J., de Graaf, W., van Son, W.J., van der Jagt, E.J. van Imhoff, G.W. (2006) PTLD Visualization by FDG-PET: improved detection of extranodal localizations. American Journal of Transplantation, 6, 1984 1985.
7. Bakker, N.A., Verschuuren, E.A.M., Erasmus, M.E., Hepkema, B.G., Veeger, N.J.G.M., Kallenberg, C.G.M. van der Bij, W. (2007) Epstein-Barr Virus-DNA load monitoring late after lung transplantation: a surrogate marker of the degree of immunosuppression and a safe guide to reduce immunosuppression. Transplantation, 83, 433 438.
8. Bates, W.D., Gray, D.W.R., Dada, M.A., Chetty, R., Gatter, K.C., Davies, D.R. Morris, P.J. (2003) Lymphoproliferative disorders in Oxford renal transplant recipients. Journal of Clinical Pathology, 56, 439 446.
9. Beveridge, T., Krupp, P. McKibbin, C. (1984) Lymphomas and lymphoproliferative lesions developing under cyclosporin therapy. The Lancet, 323, 788.
10. Bingler, M., Feingold, B., Miller, S., Quivers, E., Michaels, M., Green, M., Wadowsky, R., Rowe, D. Webber, S. (2008) Chronic high Epstein-Barr viral load state and risk for late-onset posttransplant lymphoproliferative disease/lymphoma in children. American Journal of Transplantation, 8, 442 445.
11. Blachar, A. Federle, M.P. (2001) Bowel obstruction following liver transplantation: clinical and CT findings in 48 cases with emphasis on internal hernia. Radiology, 218, 384 388.
12. Boubenider, S., Hiesse, C., Goupy, C., Kriaa, F., Marchand, S. Charpentier, B. (1997) Incidence and consequences of post-transplantation lymphoproliferative disorders. Journal of Nephrology, 10, 136 145.
13. Brennan, K.C., Lowe, L.H. Yeaney, G.A. (2005) Pediatric central nervous system posttransplant lymphoproliferative disorder. American Journal of Neuroradiology, 26, 1695 1697.
14. Bronster, D.J., Emre, S., Boccagni, P., Sheiner, P.A., Schwartz, M.E. Miller, C.M. (2000) Central nervous system complications in liver transplant recipients - incidence, timing, and long-term follow-up. Clinical Transplantation, 14, 1 7.
15. Broughton, S., McClay, J.E., Murray, A., Timmons, C., Sommerauer, J., Andrews, W. Harkins, P. (2000) The effectiveness of tonsillectomy in diagnosing lymphoproliferative disease in pediatric patients after liver transplantation. Archives of Otolaryngology - Head & Neck Surgery, 126, 1444 1447.
16. Buell, J.F., Gross, T.G., Hanaway, M.J., Trofe, J., Roy-Chaudhury, P., First, M.R. Woodle, E.S. (2005) Posttransplant lymphoproliferative disorder: significance of central nervous system involvement. Transplantation Proceedings, 37, 954 955.
17. Burns, D. Crawford, D. (2004) Epstein-Barr virus-specific cytotoxic T-lymphocytes for adoptive immunotherapy of post-transplant lymphoproliferative disease. Blood reviews, 18, 193 209.
18. Caillard, S., Agodoa, L.Y., Bohen, E.M. Abbott, K.C. (2006) Myeloma, Hodgkin disease, and lymphoid leukemia after renal transplantation: characteristics, risk factors and prognosis. Transplantation, 81, 888 895.
19. Cao, S., Cox, K., Berquist, W., Hayashi, M., Concepcion, W., Hammes, G., Ojogho, O., So, S., Frerker, M., Castillo, R., Monge, H. Esquivel, C. (1999) Long-term outcomes in pediatric liver recipients: comparison between cyclosporin A and tacrolimus. Pediatric Transplantation, 3, 22 26.
20. Cao, W., Goolsby, C.L., Nelson, B.P., Singhal, S., Mehta, J. Peterson, L.C. (2008) Instability of immunophenotype in plasma cell myeloma. American Journal of Clinical Pathology, 129, 926 933.
21. Capello, D., Rasi, S., Oreste, P., Veronese, S., Cerri, M., Ravelli, E., Rossi, D., Minola, E., Colosimo, A., Gambacorta, M., Muti, G., Morra, E. Gaidano, G. (2009) Molecular characterization of post-transplant lymphoproliferative disorders of donor origin occurring in liver transplant recipients. Journal of Pathology, 218, 478 486.
22. Carr, R., Barrington, S.F., Madan, B., O'Doherty, M.J., Saunders, C.A.B., van der Walt, J. Timothy, A.R. (1998) Detection of LYMPHOMA in bone marrow by whole-body positron emission tomography. Blood, 91, 3340 3346.
23. Casaccia, M., Torelli, P., Cavaliere, D., Panaro, F., Nardi, I., Rossi, E., Spriano, M., Bacigalupo, A., Gentile, R. Valente, U. (2007) Laparoscopic lymph node biopsy in intra-abdominal lymphoma: high diagnostic accuracy achieved with a minimally invasive procedure. Surgical Laparoscopic Endoscopic Percutaneous Techniques, 17, 175 178.
24. Castellano-Sanchez, A., Li, S., Qian, J., Lagoo, A., Weir, E. Brat, D. (2004) Primary central nervous system posttransplant lymphoproliferative disorders. American Journal of Clinical Patholology, 121, 246 253.
25. Chapman, T. Keating, G. (2003) Basiliximab: a review of its use as induction therapy in renal transplantation. Drugs, 63, 2803 2835.
26. Choong, C.K., Haddad, F.J., Huddleston, C.B., Bell, J., Guthrie, T.J., Mendeloff, E.N., Schuler, P., De la Morena, M. Sweet, S.C. (2006) Role of open lung biopsy in lung transplant recipients in a single children's hospital: a 13-year experience. Journal of Thoracic & Cardiovascular Surgery, 131, 204 208.
27. Ciancio, G., Burke, G., Gaynor, J., Sageshima, J., Herrada, E., Tueros, L., Roth, D., Kupin, W., Rosen, A., Esquenazi, V. Miller, J. (2008) Campath-1H induction therapy in African American and Hispanic first renal transplant recipients: 3-year actuarial follow-up. Transplantation, 85, 507 516.
28. Collins, J., Muller, N.L., Leung, A.N., McGuinness, G., Mergo, P.J., Flint, J.D., Warner, T.F., Poirier, C., Theodore, J., Zander, D. Yee, H.T. (1998) Epstein-Barr-virus-associated lymphoproliferative disease of the lung: CT and histologic findings. Radiology, 208, 749 759.
29. Comoli, P., Labirio, M., Basso, S., Baldanti, F., Grossi, P., Furione, M., Vigano, M., Fiocchi, R., Rossi, G., Ginevri, F., Gridelli, B., Moretta, A., Montagna, D., Locatelli, F., Gerna, G. Maccario, R. (2002) Infusion of autologous Epstein-Barr virus (EBV)-specific cytotoxic T cells for prevention of EBV-related lymphoproliferative disorder in solid organ transplant recipients with evidence of active virus replication. Blood, 99, 2592 2598.
30. Comoli, P., Maccario, R., Locatelli, F., Valente, U., Basso, S., Garaventa, A., Tomà, P., Botti, G., Meliol, G., Baldanti, F., Nocera, A., Perfumo, F. Ginevri, F. (2005) Treatment of EBV-related post-renal transplant lymphoproliferative disease with a tailored regimen including EBV-specific T cells. American Journal of Transplantation, 5, 1415 1422.
31. Copp, D.H., Godwin, J.D., Kirby, K.A. Limaye, A.P. (2006) Clinical and radiologic factors associated with pulmonary nodule etiology in organ transplant recipients. American Journal of Transplantation, 6, 2759 2764.
32. Cox, K., Lawrence-Miyasaki, L., Garcia-Kennedy, R., Lennette, E., Martinez, O., Krams, S., Berquist, W., So, S. Esquivel, C. (1995) An increased incidence of Epstein-Barr virus infection and lymphoproliferative disorder in young children on FK506 after liver transplantation. Transplantation, 59, 524 529.
33. Crawford, D.H., Thomas, J.A., Janossy, G., Sweny, P., Fernando, O.N., Moorhead, J.F. Thompson, J.H. (1980) Epstein Barr virus nuclear antigen positive lymphoma after cyclosporin: a treatment in patients with renal allograft. The Lancet, 315, 1355 1356.
34. Crespo-Leiro, M.G., Alonso-Pulpon, L., Arizon, J.M., Almenar, L., Delgado, J.F., Palomo, J., Manito, N., Rabago, G., Lage, E., Diaz, B., Roig, E., Pascual, D., Blasco, T., de la Fuente, L., Camprecios, M., Vazquez de Prada, J.A. Muniz, J. (2007) Influence of induction therapy, immunosuppressive regimen and anti-viral prophylaxis on development of lymphomas after heart transplantation: data from the Spanish Post-Heart Transplant Tumour Registry. Journal of Heart & Lung Transplantation, 26, 1105 1109.
35. Dharnidharka, V.R., Ho, P.-L., Stablein, D.M., Harmon, W.E. Tejani, A.H. (2002) Mycophenolate, tacrolimus and post-transplant lymphoproliferative disorder: a report of the North American Pediatric Renal Transplant Cooperative Study. Pediatric Transplantation, 6, 396 399.
36. Dhillon, M.S., Rai, J.K., Gunson, B.K., Olliff, S. Olliff, J. (2007) Post-transplant lymphoproliferative disease in liver transplantation. British Journal of Radiology, 80, 337 346.
37. Dockrell, D.H., Strickler, J.G. Paya, C.V. (1998) Epstein-Barr virus-induced T cell lymphoma in solid organ transplant recipients. Clinical Infectious Diseases, 26, 180 182.
38. Dolcetti, R. (2007) B lymphocytes and Epstein-Barr virus: the lesson of post-transplant lymphoproliferative disorders. Autoimmunity Reviews, 7, 96 101.
39. Dotti, G., Fiocchi, R., Motta, T., Mammana, C., Gotti, E., Riva, S., Cornelli, P., Gridelli, B., Viero, P., Oldani, E., Ferrazzi, P., Remuzzi, G., Barbui, T. Rambaldi, A. (2002) Lymphomas occurring late after solid-organ transplantation: influence of treatment on the clinical outcome. Transplantation, 74, 1095 1102.
40. Dror, Y., Greenberg, M., Taylor, G., Superina, R., Hebert, D., West, L., Connolly, B., Sena, L., Allen, U. Weitzman, S. (1999) Lymphoproliferative disorders after organ transplantation in children. Transplantation, 67, 990 998.
41. El-Salem, M., Raghunath, P., Marzec, M., Wlodarski, P., Tsai, D., Hsi, E. Wasik, M. (2007) Constitutive activation of mTOR signaling pathway in post-transplant lymphoproliferative disorders. Laboratory Investigation, 87, 29 39. (Pubitemid 44973651)
42. Emery, V.C., Cope, A.V., Bowen, E.F., Gor, D. Griffiths, P.D. (1999) The dynamics of human cytomegalovirus replication in Vivo. Journal of Experimental Medicine, 190, 177 182.
43. von Falck, C., Maecker, B., Schirg, E., Boerner, A.R., Knapp, W.H., Klein, C. Galanski, M. (2007) Post transplant lymphoproliferative disease in pediatric solid organ transplant patients: a possible role for [18F]-FDG-PET(/CT) in initial staging and therapy monitoring. European Journal of Radiology, 63, 427 435.
44. Feng, S., Buell, J.F., Chari, R.S., DiMaio, J.M. Hanto, D.W. (2003) Tumors and transplantation: the 2003 third annual ASTS State-of-the-Art Winter Symposium. American Journal of Transplantation, 3, 1481 1487.
45. Ganschow, R., Grabhorn, E., Schulz, A., Von Hugo, A., Rogiers, X. Burdelski, M. (2005) Long-term results of basiliximab induction immunosuppression in pediatric liver transplant recipients. Pediatric Transplantation, 9, 741 745.
46. Gao, S.Z., Perlroth, M.G., Schroeder, J.S., Montoya, J.G., Miller, J.L., DiMiceli, S., Brown, B. Oyer, P.E. (2002) Thirty year experience with non-lymphoma cancer post heart and heart-lung transplantation at Stanford. The Journal of Heart and Lung Transplantation, 21, 118 119.
47. Gattuso, P., Castelli, M., Peng, Y. Reddy, V. (1997) Posttransplant lymphoproliferative disorders: a fine-needle aspiration biopsy study. Diagnostic Cytopathology, 16, 392 395.
48. Green, M., Cacciarelli, T., Mazariegos, G., Sigurdsson, L., Qu, L., Rowe, D. Reyes, J. (1998) Serial measurement of Epstein-Barr viral load in peripheral blood in pediatric liver transplant recipients during treatment for posttransplant lymphoproliferative disease. Transplantation, 66, 1641 1644.
49. Green, M., Soltys, K., Rowe, D., Webber, S. Mazareigos, G. (2009) Chronic high Epstein-Barr viral load carriage in pediatric liver transplant recipients. Pediatric Transplantation, 13, 319 323.
50. Guppy, A.E., Rawlings, E., Madrigal, J.A., Amlot, P.L. Barber, L.D. (2007) A quantitative assay for Epstein-Barr Virus-specific immunity shows interferon-gamma producing CD8+ T cells increase during immunosuppression reduction to treat posttransplant lymphoproliferative disease. Transplantation, 84, 1534 1539.
51. Halkos, M.E., Miller, J.I., Mann, K.P., Miller, D.L. Gal, A.A. (2004) Thoracic presentations of posttransplant lymphoproliferative disorders. Chest, 126, 2013 2020.
52. Haque, T., Wilkie, G.M., Taylor, C., Amlot, P.L., Murad, P., Iley, A., Dombagoda, D., Britton, K.M., Swerdlow, A.J. Crawford, D.H. (2002) Treatment of Epstein-Barr virus-positive post-transplant lymphoproliferative disease with partly HLA-matched allogeneic cytotoxic T cells. Lancet, 360, 436 441.
53. Haque, T., Wilkie, G.M., Jones, M.M., Higgins, C.D., Urquhart, G., Wingate, P., Burns, D., McAulay, K., Turner, M., Bellamy, C., Amlot, P.L., Kelly, D., MacGilchrist, A., Gandhi, M.K., Swerdlow, A.J. Crawford, D.H. (2007) Allogeneic cytotoxic T-cell therapy for EBV-positive posttransplantation lymphoproliferative disease: results of a phase 2 multicenter clinical trial. Blood, 110, 1123 1131.
54. Harris, N.L., Ferry, J.A. Swerdlow, S.H. (1997) Posttransplant lymphoproliferative disorders: summary of Society for Hematopathology Workshop. Seminars in Diagnostic Pathology, 14, 8 14.
55. Harris, N.L., Swerdlow, S.H., Frizzera, G. Knowles, D.M. (2001) Post-transplant lymphoproliferative disorders. In : Pathology & Genetics: Tumours of Haematopoietic and Lymphoid Tissues (eds by E.S. Jaffe, N.L. Harris, H. Stein J.W. Vardiman pp. 264 271. IARC Press
56. Hézode, C., Duvoux, C., Germanidis, G., Roudot-Thoraval, F., Vincens, A.-L., Gaulard, P., Cherqui, D., Pawlotsky, J.-M. Dhumeaux, D. (1999) Role of hepatitis C virus in lymphoproliferative disorders after liver transplantation. Hepatology, 30, 775 778.
57. Hoshida, Y., Li, T., Dong, Z., Tomita, Y., Yamauchi, A., Hanai, J. Aozasa, K. (2001) Lymphoproliferative disorders in renal transplant patients in Japan. International Journal of Cancer, 91, 869 875.
58. Hsi, E.D., Singleton, T.P., Swinnen, L., Dunphy, C.H. Alkan, S. (2000) Mucosa-associated lymphoid tissue-type lymphomas occurring in post-transplantation patients. American Journal of Surgical Pathology, 24, 100 106.
59. Ison, M.G. Nalesnik, M. (2009) OPTN/UNOS Ad Hoc Disease Transmission Advisory Committee Report to the Board of Directors. November 16-17, 2009
60. Jaber, J., Feustel, P., Elbahloul, O., Conti, A., Gallichio, M. Conti, D. (2007) Early steroid withdrawal therapy in renal transplant recipients: a steroid-free sirolimus and CellCept-based calcineurin inhibitor-minimization protocol. Clinical Transplantation, 21, 101 109.
61. Juweid, M.E. Cheson, B.D. (2006) Positron-emission tomography and assessment of cancer therapy. New England Journal of Medicine, 354, 496 507.
62. Juweid, M.E., Stroobants, S., Hoekstra, O.S., Mottaghy, F.M., Dietlein, M., Guermazi, A., Wiseman, G.A., Kostakoglu, L., Scheidhauer, K., Buck, A., Naumann, R., Spaepen, K., Hicks, R.J., Weber, W.A., Reske, S.N., Schwaiger, M., Schwartz, L.H., Zijlstra, J.M., Siegel, B.A. Cheson, B.D. (2007) Use of positron emission tomography for response assessment of lymphoma: consensus of the imaging subcommittee of international harmonization project in lymphoma. Journal of Clinical Oncology, 25, 571 578.
63. Kaplan, M.A., Ferry, J.A., Harris, N.L. Jacobson, J.O. (1994) Clonal analysis of posttransplant lymphoproliferative disorders, using both episomal Epstein-Barr virus and immunoglobulin genes as markers. American Journal of Clinical Pathology, 101, 590 596.
64. Katz, B.Z., Pahl, E., Crawford, S.E., Kostyk, M.C., Rodgers, S., Seshadri, R., Proytcheva, M. Pophal, S. (2007) Case-control study of risk factors for the development of post-transplant lymphoproliferative disease in a pediatric heart transplant cohort. Pediatric Transplantation, 11, 58 65.
65. Khan, W.A., Yu, L., Eisenbrey, A.B., Crisan, D., Al Saadi, A., Davis, B.H., Hankin, R.C. Mattson, J.C. (2001) Hepatosplenic gamma/delta T-Cell Lymphoma in Immunocompromised Patients. American Journal of Clinical Pathology, 116, 41 50.
66. Khwaja, K., Asolati, M., Harmon, J., Melancon, J., Dunn, T., Gillingham, K., Kandaswamy, R., Humar, A., Gruessner, R., Payne, W., Najarian, J., Dunn, D., Sutherland, D. Matas, A. (2004) Outcome at 3 years with a prednisone-free maintenance regimen: a single-center experience with 349 kidney transplant recipients. American Journal of Transplantation, 4, 980 987.
67. Kremers, W.K., Devarbhavi, H.C., Wiesner, R.H., Krom, R.A., Macon, W.R. Habermann, T.M. (2006) Post-transplant lymphoproliferative disorders following liver transplantation: incidence, risk factors and survival. American Journal of Transplantation, 6, 1017 1024.
68. Kwee, T.C., Kwee, R.M. Nievelstein, R.A.J. (2008) Imaging in staging of malignant lymphoma: a systematic review. Blood, 111, 504 516.
69. Kwong, Y.L., Lam, C.C.K. Chan, T.M. (2000) Post-transplantation lymphoproliferative disease of natural killer cell lineage: a clinicopathological and molecular analysis. British Journal of Haematology, 110, 197 202.
70. Lau, L.G., Tan, L.K., Salto-Tellez, M., Koay, E.S. Liu, T.C. (2004) T-cell post-transplant lymphoproliferative disorder after hematopoietic stem cell transplantation: another case and a review of the literature Bone Marrow Transplantation, 34, 821 822.
71. Leblond, V., Sutton, L., Dorent, R., Davi, F., Bitker, M.O., Gabarre, J., Charlotte, F., Ghoussoub, J.J., Fourcade, C. Fischer, A. (1995) Lymphoproliferative disorders after organ transplantation: a report of 24 cases observed in a single center. Journal of Clinical Oncology, 13, 961 968.
72. Leblond, V., Davi, F., Charlotte, F., Dorent, R., Bitker, M.O., Sutton, L., Gandjbakhch, I., Binet, J.L. Raphael, M. (1998) Posttransplant lymphoproliferative disorders not associated with Epstein-Barr virus: a distinct entity? Journal of Clinical Oncology, 16, 2052.
73. Lee, T.C., Savoldo, B., Rooney, C.M., Heslop, H.E., Gee, A.P., Caldwell, Y., Barshes, N.R., Scott, J.D., Bristow, L.J., O'Mahony, C.A. Goss, J.A. (2005) Quantitative EBV viral loads and immunosuppression alterations can decrease PTLD incidence in pediatric liver transplant recipients. American Journal of Transplantation, 5, 2222 2228.
74. Libertiny, G., Watson, C.J., Gray, D.W., Welsh, K.I. Morris, P.J. (2001) Rising incidence of post-transplant lymphoproliferative disease in kidney transplant recipients. British Journal of Surgery, 88, 1330 1334.
75. Macedo, C., Donnenberg, A., Popescu, I., Reyes, J., Abu-Elmagd, K., Shapiro, R., Zeevi, A., Fung, J.J., Storkus, W.J. Metes, D. (2005) EBV-specific memory CD8+ T cell phenotype and function in stable solid organ transplant patients. Transplant Immunology, 14, 109 116.
76. Marom, E.M., McAdams, H.P., Butnor, K.J. Coleman, R.E. (2004) Positron emission tomography with fluoro-2-deoxy-D-glucose (FDG-PET) in the staging of post transplant lymphoproliferative disorder in lung transplant recipients. Journal of Thoracic Imaging, 19, 74 78.
77. McCormack, L., Hany, T.I., Hubner, M., Petrowsky, H., Mullhaupt, B., Knuth, A., Stenner, F. Clavien, P.-A. (2006) How useful is PET/CT imaging in the management of post-transplant lymphoproliferative disease after liver transplantation? American Journal of Transplantation, 6, 1731 1736.
78. Morrison, V.A., Dunn, D.L., Manivel, J.C., Gajl-Peczalska, K.J. Peterson, B.A. (1994) Clinical characteristics of post-transplant lymphoproliferative disorders. The American Journal of Medicine, 97, 14 24.
79. Nalesnik, M.A. (2001) The diverse pathology of post-transplant lymphoproliferative disorders: the importance of a standardized approach. Transplant Infectious Disease, 3, 88 96.
80. Nelson, B., Nalesnik, M., Bahler, D., Locker, J., Fung, J. Swerdlow, S. (2000) Epstein-Barr virus-negative post-transplant lymphoproliferative disorders: a distinct entity? American Journal of Surgical Pathology, 24, 375 385.
81. Newell, K., Alonso, E., Whitington, P., Bruce, D., Millis, J., Piper, J., Woodle, E., Kelly, S., Koeppen, H., Hart, J., Rubin, C. Thistlethwaite, J.J. (1996) Posttransplant lymphoproliferative disease in pediatric liver transplantation. Interplay between primary Epstein-Barr virus infection and immunosuppression. Transplantation, 62, 370 375.
82. Newman, J.S., Francis, I.R., Kaminski, M.S. Wahl, R.L. (1994) Imaging of lymphoma with PET with 2-[F-18]-fluoro-2-deoxy-D-glucose: correlation with CT. Radiology, 190, 111 116.
83. O'Conner, A.R. Franc, B.L. (2005) FDG PET imaging in the evaluation of post-transplant lymphoproliferative disorder following renal transplantation. Nuclear Medicine Communications, 26, 1107 1111.
84. O'Neill, J.O., Edwards, L.B. Taylor, D.O. (2006) Mycophenolate mofetil and risk of developing malignancy after orthotopic heart transplantation: analysis of the transplant registry of the international society for heart and lung transplantation. The Journal of Heart and Lung Transplantation, 25, 1186 1191.
85. Opelz, G. Döhler, B. (2004) Lymphomas after solid organ transplantation: a collaborative transplant study report. American Journal of Transplantation, 4, 222 230.
86. Opelz, G. Henderson, R. (1993) Incidence of non-Hodgkin lymphoma in kidney and heart transplant recipients. Lancet, 342, 1514.
87. Ortiz, J., Palma-Vargas, J., F, W., A, B., Agha, I., Rosenblatt, S. Foster, P. (2008) Campath induction for kidney transplantation: report of 297 cases. Transplantation, 85, 1550 1556.
88. Park, S., Lee, J., Ko, Y.H., Han, A., Jun, H.J., Lee, S.C., Hwang, I.G., Park, Y.H., Ahn, J.S., Jung, C.W., Kim, K., Ahn, Y.C., Kang, W.K., Park, K. Kim, W.S. (2007) The impact of Epstein-Barr virus status on clinical outcome in diffuse large B-cell lymphoma. Blood, 110, 972 978.
89. Parker, A., Bain, B., Devereux, S., Gatter, K., Jack, A., Matutes, E., Rooney, N., Ross, F., Wilkins, B., Wotherspoon, A. Ramsay, A. (2007) Best Practice in Lymphoma Diagnosis and Reporting. British Committee for Standards in Haematology. WWW document. URL. http://www.bcshguidelines.com/pdf/best- practice-lymphoma-diagnosis.pdf.
90. Parker, A., Amlot, P., Bowles, K., Bradley, J.A., Emery, V., Featherstone, C., Gupte, G., Marcus, R., Parameshwar, J., Ramsay, A. Newstead, C. (2009) Guidelines on the surveillance, diagnosis and management of post-transplant lymphoproliferative Disorders in adult solid organ transplant recipients. WWW document. URL. http://www.bcshguidelines.com/pdf/pltd- finaldraft-071009.pdf.
91. Penn, I. Porat, G. (1995) Central nervous system lymphomas in organ allograft recipients. Transplantation, 59, 240 244.
92. Pickhardt, P.J. Siegel, M.J. (1999) Posttransplantation lymphoproliferative disorder of the abdomen: CT evaluation in 51 patients. Radiology, 213, 73 78.
93. Pitman, S.D., Rowsell, E.H., Cao, J.D., Huang, Q. Wang, J. (2004) Anaplastic large cell lymphoma associated with Epstein-Barr virus following cardiac transplant. American Journal of Surgical Pathology, 28, 410 415.
94. Posey, L.A., Kerschner, J.E. Conley, S.F. (1999) Posttransplantation lymphoproliferative disease in children: otolaryngologic manifestations and management. Southern Medical Journal, 92, 1079 1082.
95. Purtilo, D. (1980) Epstein-Barr-virus-induced oncogenesis in immune-deficient individuals. Lancet, 1, 300 303.
96. Reams, B.D., McAdams, H.P., Howell, D.N., Steele, M.P., Davis, R.D. Palmer, S.M. (2003) Posttransplant lymphoproliferative disorder: incidence, presentation, and response to treatment in lung transplant recipients. Chest, 124, 1242 1249.
97. Reding, R., Wallemacq, P., Lamy, M., Rahier, J., Sempoux, C., Debande, B., Jamart, J., Barker, A., Sokal, E. De Ville de Goyet, J. (1994) Conversion from cyclosporine to FK506 for salvage of immunocompromised pediatric liver allografts. Efficacy, toxicity, and dose regimen in 23 children. Transplantation, 57, 93 100.
98. Rees, L., Thomas, J.A. Amlot, P.L. (1998) Disappearance of an EBV+ posttransplant plasmacytoma with controlled reduction of immunosuppression. Lancet, 352, 789.
99. Reynolds, D.J., Banks, P.M. Gulley, M.L. (1995) New characterization of infectious mononucleosis and a phenotypic comparison with Hodgkin's disease. American Journal of Pathology, 146, 379 388.
100. Riebel, T., Kebelmann-Betzing, C. Scheer, I. (2007) Ultrasound in abdominal and soft-tissue childhood PTLD (post-transplant lymphoproliferative disease). Ultraschall in der Medizin, 28, 201 205.
101. Robson, R., Cecka, J.M., Opelz, G., Budde, M. Sacks, S. (2005) Prospective registry-based observational cohort study of the long-term risk of malignancies in renal transplant patients treated with mycophenolate mofetil. American Journal of Transplantation, 5, 2954 2960.
102. Rüdiger, T., Jaffe, E., Delsol, G., deWolf-Peeters, C., Gascoyne, R., Georgii, A., Harris, N., Kadin, M., MacLennan, K., Poppema, S., Stein, H., Weiss, L. Müller-Hermelink, H. (1998) Workshop report on Hodgkin's disease and related diseases 'grey zone' lymphoma. Annals of Oncology, 9, S31 S38.
103. Sabnani, I., Zucker, M.J., Tsang, P. Palekar, S. (2006) Clonal T-large granular lymphocyte proliferation in solid organ transplant recipients. Transplant Proceedings, 38, 3437 3440.
104. von Schulthess, G.K., Steinert, H.C. Hany, T.F. (2006) Integrated PET/CT: current applications and future directions. Radiology, 238, 405 422.
105. Seam, P., Juweid, M.E. Cheson, B.D. (2007) The role of FDG-PET scans in patients with lymphoma. Blood, 110, 3507 3516.
106. Sebelin-Wulf, K., Nguyen, T.D., Oertel, S., Papp-Vary, M., Trappe, R.U., Schulzki, A., Pezzutto, A., Riess, H. Subklewe, M. (2007) Quantitative analysis of EBV-specific CD4/CD8 T cell numbers, absolute CD4/CD8 T cell numbers and EBV load in solid organ transplant recipients with PLTD. Transplant Immunology, 17, 203 210.
107. Selvaggi, G., Sarkar, S., Mittal, N., Acar, B.C., Weppler, D., Kato, T., Tryphonopoulos, P., Tzakis, A. Ruiz, P. (2006) Etiology and management of alimentary tract ulcers in pediatric intestinal transplantation patients. Transplantation Proceedings, 38, 1768 1769.
108. Sherritt, M.A., Bharadwaj, M., Burrows, J.M., Morrison, L.E., Elliott, S.L., Davis, J.E., Kear, L.M., Slaughter, R.E., Bell, S.C., Galbraith, A.J., Khanna, R. Moss, D.J. (2003) Reconstitution of the latent T-lymphocyte response to Epstein-Barr virus is coincident with long-term recovery from posttransplant lymphoma after adoptive immunotherapy. Transplantation, 75, 1556 1560.
109. Siddiqui, M., Reddy, V., Castelli, M. Gattuso, P. (1997) Role of fine-needle aspiration in clinical management of transplant patients. Diagnostic Cytopathology, 17, 429 435.
110. Smets, F., Latinne, D., Bazin, H., Reding, R., Otte, J., Buts, J. Sokal, E. (2002) Ratio between Epstein-Barr viral load and anti-Epstein-Barr virus specific T-cell response as a predictive marker of posttransplant lymphoproliferative disease. Transplantation, 73, 1603 1610.
111. Smith, J.M., Rudser, K., Gillen, D., Kestenbaum, B., Seliger, S., Weiss, N., McDonald, R.A., Davis, C.L. Stehmen-Breen, C. (2006) Risk of lymphoma after renal transplantation varies with time: an analysis of the United States Renal Data System. Transplantation, 81, 175 180.
112. Smith, J.M., Corey, L., Healey, P.J., Davis, C.L. McDonald, R.A. (2007) Adolescents are more likely to develop posttransplant lymphoproliferative disorder after primary Epstein-Barr virus infection than younger renal transplant recipients. Transplantation, 83, 1423 1428.
113. Starzl, T.E., Porter, K.A., Iwatsuki, S., Rosenthal, J.T., Shaw, B.W., Atchison, R.W., Nalesnik, M.A., Ho, M., Griffith, B.P., Hakala, T.R., Hardesty, R.L., Jaffe, R. Bahnson, H.T. (1984) Reversibility of lymphomas and lymphoproliferative lesions developing under cyclosporin-steroid therapy. The Lancet, 323, 583 587.
114. Stevens, S.J.C., Verschuuren, E.A.M., Pronk, I., van der Bij, W., Harmsen, M.C., The, T.H., Meijer, C.J.L.M., van der Brule, A.J.C. Middledorp, J.M. (2001) Frequent monitoring of Epstein-Barr virus DNA load in unfractionated whole blood is essential for early detection of posttransplant lymphoproliferative disease in high-risk patients. Blood, 97, 1165 1171.
115. Stevens, S.J., Verkuijlen, S.A. Middeldorp, J.M. (2005) Quantitative detection of Epstein-Barr virus DNA in clinical specimens by rapid real-time PCR targeting a highly conserved region of EBNA-1. Methods in Molecular Biology, 292, 15 26.
116. Strang, G. Rickinson, A. (1987) In vitro expansion of Epstein-Barr virus-specific HLA-restricted cytotoxic T cells direct from the blood of infectious mononucleosis patients. Immunology, 62, 647 654.
117. Sun, X., Peterson, L.C., Gong, Y., Traynor, A.E. Nelson, B.P. (2004) Post-transplant plasma cell myeloma and polymorphic lymphoproliferative disorder with monoclonal serum protein arising in solid organ transplant recipients Modern Pathology, 17, 389 394.
118. Swerdlow, S.H., Webber, S.A., Chadburn, A. Ferry, J.A. (2008a) Post-transplant lymphoproliferative disorders (PTLD). In : WHO Classification of Tumours of Haematopoietic and Lymphoid Tissue (eds by S.H. Swerdlow, E. Campo, N.L. Harris, E.S. Jaffe, S.A. Pileri, H. Stein, J. Thiele J.W. Vardiman pp. 343 350. IARC
119. Swerdlow, S.H., Campo, E., Harris, N.L., Jaffe, E.S., Pileri, S.A., Stein, H., Thiele, J. Vardiman, J.W. (eds 2008b) WHO Classification of Tumours of Haematopoietic and Lymphoid Tissues. IARC
120. Tsai, D.E., Aqui, N.A., Vogl, D.T., Bloom, R.D., Schuster, S.J., Nasta, S.D. Wasik, M.A. (2005) Successful treatment of T-cell post-transplant lymphoproliferative disorder with the retinoid analog bexarotene. American Journal of Transplantation, 5, 2070 2073.
121. Tsao, L. Hsi, E.D. (2007) The clinicopathologic spectrum of posttransplantation lymphoproliferative disorders. Archives in Pathology and Laboratory Medicine, 131, 1209 1218.
122. Tsao, L., Draoua, H.Y., Mansukhani, M., Bhagat, G. Alobeid, B. (2004) EBV-associated, extranodal NK-cell lymphoma, nasal type of the breast, after heart transplantation. Modern Pathology, 17, 125 130.
123. Tsao, L., Chu, K.E., Bhagat, G. Alobeid, B. (2006) Development of hairy cell leukemia in a patient after cardiac transplantation. Leukemia and Lymphoma, 47, 361 363.
124. Whelass, S.A., Gulley, M.L., Raab-Traub, N., McNeillie, P., Neuringer, I.P., Ford, H.J. Aris, R.M. (2008) Post-transplantation lymphoproliferative disease. Epstein - barr virus DNA levels, HLA-A3 and survival. American Journal of Respiratory and Critical Care Medicine, 178, 1060 1065.
125. Wotherspoon, A., Diss, T., Pan, L., Singh, N., Whelan, J. Isaacson, P. (1996) Low grade gastric B-cell lymphoma of mucosa associated lymphoid tissue in immunocompromised patients. Histopathology, 28, 129 134.
126. Yang, J., Lemas, V.M., Flinn, I.W., Krone, C. Ambinder, R.F. (2000) Application of the ELISPOT assay to the characterization of CD8+ responses to Epstein-Barr virus antigens. Blood, 95, 241 248.
127. Yin, C.C., Medeiros, L.J., Abruzzo, L.V., Jones, D., Farhood, A.I. Thomazy, V.A. (2005) EBV-associated B- and T-cell posttransplant lymphoproliferative disorders following primary EBV infection in a kidney transplant recipient. American Journal of Clinical Pathology, 123, 222 228.
128. Younes, B., McDiarmid, S., Martin, M., Vargas, J., Goss, J., Busuttil, R. Ament, M. (2000) The effect of immunosuppression on posttransplant lymphoproliferative disease in pediatric liver transplant patients. Transplantation, 70, 94 99.